Infectious Disease & Vaccines

Many of the same therapies used to activate the immune system against cancer may also combat infectious diseases.

Antimicrobial resistance poses a significant threat to healthcare. Ultra-microscopic viruses called bacteriophages might hold a solution.

Viral diseases like hepatitis don’t have many successful treatments available, so scientists are engineering antibodies to try and change that.

Scientists weaponize the symbiotic bacteria in mosquitoes against the deadly diseases they transmit.

The best scientific presentations are not just about the science. The delivery matters too.

Pioneering approaches transform vaccine technologies and shape the future of disease prevention.

Researchers precisely engineered an antibody to better treat respiratory depression due to overdose from increasingly prevalent synthetic opioids.

Inhibitors of an enzyme essential for schistosomiasis parasitic infection effectively combat the condition in mice.

Last year, the USDA conditionally approved an oral vaccine for mice to reduce the transmission of Lyme disease to humans.

Using a machine learning approach, researchers discovered how to make mouse macrophages resistant to tuberculosis infection.

A novel system for procuring leaf samples leads researchers to a new amino acid and a promising antifungal drug candidate.

Since antibiotics tend to have negative side effects on the gut, researchers sought an alternative in an unexpected place: yogurt.